Copyright
©The Author(s) 2004.
World J Gastroenterol. Oct 15, 2004; 10(20): 3048-3052
Published online Oct 15, 2004. doi: 10.3748/wjg.v10.i20.3048
Published online Oct 15, 2004. doi: 10.3748/wjg.v10.i20.3048
Group | Dose (mg/kg) | n | Last body mass(g ) | t value | Survival time (d ) | t value | ||
Alone | With 5-FU | Alone | With 5-FU | |||||
Control | 0 | 8 | 23.6 ± 2.0 | 17.3 ± 3.3 | ||||
RES | 10.0 | 8 | 23.8 ± 1.2 | 21.5 ± 5.6 | ||||
5-FU | 20.0 | 8 | 16.5 ± 1.8 | 20.3 ± 1.3 | 4.79b | 32.0 ± 9.7 | 44.6 ± 11.6 | 2.34a |
10.0 | 8 | 19.6 ± 1.8 | 23.2 ± 2.5 | 3.25b | 23.6 ± 5.4 | 36.3 ± 9.4 | 3.22b | |
5.0 | 8 | 21.3 ± 1.7 | 24.5 ± 1.5 | 3.80b | 19.5 ± 4.4 | 30.6 ± 8.0 | 3.48b |
- Citation: Wu SL, Sun ZJ, Yu L, Meng KW, Qin XL, Pan CE. Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol 2004; 10(20): 3048-3052
- URL: https://www.wjgnet.com/1007-9327/full/v10/i20/3048.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i20.3048